Selexipag (UPTRAVI) tabs, pharmaceuticals.
Ended Awarded Last action
- Contract number
- 36C26025F0107
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $70,630
Award facts
- Contract value 100% obligated
- $70,629.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lake Mary, FL 32746, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$642,202 | |
| Original award | $712,832 |
About this award
This is a federal contract award to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20. The contract is for the delivery of the drug Selexipag (Uptravi), a treatment for pulmonary arterial hypertension.
The contract has a ceiling value of $70,629.56 and is a firm-fixed-price delivery order with an ultimate completion date of August 7, 2025. The contract is not set aside for small businesses.
Actelion Pharmaceuticals US, Inc. holds several Indefinite Delivery Vehicles (IDVs) with the VA, including a $219,108,390 Federal Supply Schedule (FSS-61-IB) contract and two Blanket Purchase Agreements valued at $118.5 million and $83.5 million. These IDVs allow the VA and other federal healthcare institutions to efficiently procure specialized pharmaceutical products like Selexipag for the treatment of rare diseases and pulmonary conditions among veterans, inmates, and other eligible beneficiaries.
Quick answers
Who was awarded contract 36C26025F0107?
36C26025F0107 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on February 9, 2025.
How much is contract 36C26025F0107 worth?
The government has obligated $70,630 on 36C26025F0107.
Is contract 36C26025F0107 an order under another contract?
Yes. 36C26025F0107 is a delivery order under 36F79724D0159, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0107 competed?
The extent of competition for 36C26025F0107 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award